PRO.MED.CS PRAHA A.S. IS A CZECH PHARMACEUTICAL COMPANY WITH ITS OWN STATE-OF-THE-ART SOLID PHARMACEUTICALS MANUFACTURING FACILITIES IN PRAGUE MEETING THE HIGHEST EUROPEAN STANDARDS, AS EVIDENCED BY ITS GMP, GCP, GLP, ISO CERTIFICATES.
PRO.MED.CS Praha a.s. was one of the first non-russian pharmaceutical companies to receive both russian and european GMP certificates. In 2019 company is celebrating its 30th anniversary.
PRO.MED.CS Praha a.s. manufactures over 30 drugs and annually releases and registers new medicinal products. The company also has exclusive rights to represent the drugs of other european manufacturers. PRO.MED.CS Praha a.s. supplies its products to over 30 countries, mainly the Russian Federation, as well as Central and East Europe and Central Asia.
In Russia PRO.MED.CS Praha a.s. represents drugs used in various fields of clinical medicine. Its product range includes drugs for gastroenterology, cardiology, urology, gynaecology, neurology, as well as vitamin mineral complexes, specifically: URSOSAN, INDAP, PROPANORM, ITOMED, SPASMEX, MONOSAN, SELZINC PLUS, PROMAGSAN and the new innovative drugs REBAGIT and NITREMED. The company’s share of the Russian market is 3.7%.
The successful growth of PRO.MED.CS Praha a.s. and its stable position in the pharmaceutical market are largely thanks to the fact that the company invests a considerable share of its revenue in R&D with 22% of the enterprise’s workforce employed in this area. Furthermore, PRO.MED.CS Praha a.s. holds an international competition for research works in gastroenterology and hepatology with a winner once every two years receiving the Dr. Rudolf O. Bares Award. The topics are unrelated to the company’s activities, but should be associated with main research trends in gastroenterology and hepatology.
PRO.MED.CS Praha a.s.’s mission is to offer tried and tested, high-quality, effective and safe drugs.